Long-Term Liabilities: The sum of all non-current liabilities.
Standard BioTools Inc. (LAB) had Long-Term Liabilities of $35.16M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$3.22M |
|
$19.28M |
|
$0.53M |
|
$2.69M |
|
$21.87M |
|
$-18.64M |
|
$-0.69M |
|
$-19.34M |
|
$-19.34M |
|
$16.56M |
|
$16.56M |
|
$19.28M |
|
$16.56M |
|
$-18.64M |
|
$-17.82M |
|
381.62M |
|
381.62M |
|
$0.05 |
|
$0.05 |
|
| Balance Sheet Financials | |
$454.26M |
|
$19.27M |
|
$113.49M |
|
$567.75M |
|
$108.31M |
|
$0.30M |
|
|
Long-Term Liabilities |
$35.16M |
$143.46M |
|
$424.29M |
|
$424.29M |
|
$424.29M |
|
386.38M |
|
| Cash Flow Statement Financials | |
$-74.34M |
|
$27.41M |
|
$0.57M |
|
$168.82M |
|
$123.30M |
|
$-45.52M |
|
$29.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.19 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
83.49% |
|
-578.65% |
|
-578.65% |
|
-- |
|
-600.12% |
|
598.48% |
|
$-82.65M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.03 |
|
0.24 |
|
375.17 |
|
3.90% |
|
3.90% |
|
2.92% |
|
3.90% |
|
$1.10 |
|
$-0.22 |
|
$-0.19 |
|